You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (168)

Journals (0)

1-10 of 168 results for Anti-PD-L1

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: Combination of anti-PD-L1 and radiotherapy in hepatocellular carcinoma: a mathematical model with uncertain parameters

Retricted access

Research article

First published 2023-4

Combination of anti-PD-L1 and radiotherapy in hepatocellular carcinoma: a mathematical model with uncertain parameters

Sajad Shafiekhani, Nematollah Gheibi, Azam Janati Esfahani

SIMULATION

Select article: Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Open access

Research article

First published 2020-7

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

Select article: New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Free access

Letter

First published 2016-4

New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Cheng Chen, Jian-An Huang

European Journal of Inflammation

Select article: Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells

Retricted access

Research article

First published 2025-3

Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells

Wei Wang, Sujing Zhang, Cong Wang [...]

Journal of Investigative Medicine

Select article: Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Open access

Research article

First published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology

Select article: 89 Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating In Vivo PD-L1 Levels in Melanoma Mouse Model

Retricted access

Research article

First published 2020-10

89 Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating In Vivo PD-L1 Levels in Melanoma Mouse Model

Caleb Bridgwater, Anne Geller, Xiaoling Hu [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Select article: Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Open access

Research article

First published 2022-11

Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Takashi Inoue, Mamoru Narukawa

Cancer Control

Select article: CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Open access

Case report

First published 2023

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Yuan Yuan, Colt Egelston, Oscar Colunga Flores [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
17
10 / page

Article type

Publication date

Subjects

Access